Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on A Systematic Review and Meta-Analysis
Value Health
.
2014 Nov;17(7):A382.
doi: 10.1016/j.jval.2014.08.2623.
Epub 2014 Oct 26.
Authors
S Ahmadiani
1
,
S Nikfar
1
,
S Karimi
1
,
A R Jamshidi
1
,
A Akbari-Sari
1
,
A Kebriaeezadeh
1
Affiliation
1
Tehran University of Medical Sciences, Tehran, Iran.
PMID:
27200854
DOI:
10.1016/j.jval.2014.08.2623
No abstract available